Literature DB >> 30863580

Relationship of pleural fluid pH and glucose: a multi-centre study of 2,971 cases.

Deirdre B Fitzgerald1,2,3, Su Lyn Leong1,2,3, Charley A Budgeon4, Kevin Murray5, Andrew Rosenstengal6, Nicola A Smith7, Silvia Bielsa8, Amelia O Clive9, Nick A Maskell9, José M Porcel8, Y C Gary Lee1,2,3.   

Abstract

BACKGROUND: Pleural fluid pH and glucose levels are both recommended in the workup of pleural effusions. Whether their levels correlate and predict each other or contribute independent knowledge is unclear. We aimed to investigate the pH/glucose relationship, assess their concordance and ascertain whether performing both tests provides additional information to performing either test alone.
METHODS: The pH and glucose measurements from 2,971 pleural fluid samples, from three centers in Spain, UK and Australia, were categorized into Cancer (n=1,045), Infection (n=544), Tuberculosis (n=249) and Others (n=1,133) groups. The relationship between pH and glucose values and their concordance at clinically relevant cutoffs (pH 7.2 and glucose 3.3 mmol/L) were assessed.
RESULTS: The mean pH of the cohort was 7.38 (SD 0.22) and median glucose 5.99 (range, 0.00-29.36) mmol/L. A regression model of the relationship between glucose (log-transformed) and pH with a restricted cubic spline showed linear (P<0.01) and nonlinear effects (P<0.01). The relationship was strong with a narrow confidence interval but the prediction interval was wide. Most (91.9%) samples were concordant using pH and glucose levels at cutoffs of 7.20 and 3.30 mmol/L respectively. Using pH alone, without glucose, captured 95.0% of the infection-related effusions with either pH or glucose below cutoff and glucose alone identified 91.7%.
CONCLUSIONS: Pleural fluid pH and glucose have a strong non-linear relationship but, in most situations, the level of one cannot accurately predict the other. Concordance rates were high and either test is sufficient in the majority of cases.

Entities:  

Keywords:  Clinical decision making; empyema; glucose; hydrogen-ion concentration; pleural effusion

Year:  2019        PMID: 30863580      PMCID: PMC6384369          DOI: 10.21037/jtd.2018.12.101

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  19 in total

1.  RELATIONSHIP BETWEEN CELL TYPE, GLUCOSE CONCENTRATION, AND RESPONSE TO TREATMENT IN NEOPLASTIC EFFUSIONS.

Authors:  B CLARKSON
Journal:  Cancer       Date:  1964-07       Impact factor: 6.860

2.  Glucose level in pleural fluid as a diagnostic aid.

Authors:  L M BARBER; L MAZZADI; D D DEAKINS; C N REESE; W L ROGERS
Journal:  Dis Chest       Date:  1957-06

3.  Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions.

Authors:  J E Heffner; P J Nietert; C Barbieri
Journal:  Chest       Date:  2000-01       Impact factor: 9.410

4.  Clinically important factors influencing the diagnostic measurement of pleural fluid pH and glucose.

Authors:  Najib M Rahman; Eleanor K Mishra; Helen E Davies; Robert J O Davies; Y C Gary Lee
Journal:  Am J Respir Crit Care Med       Date:  2008-06-12       Impact factor: 21.405

5.  Survival time of patients with pleural metastatic carcinoma predicted by glucose and pH studies.

Authors:  F Rodriguez-Panadero; J Lopez-Mejias
Journal:  Chest       Date:  1989-02       Impact factor: 9.410

6.  Etiology and prognostic significance of massive pleural effusions.

Authors:  David Jiménez; Gema Díaz; Daniel Gil; Ana Cicero; Esteban Pérez-Rodríguez; Antonio Sueiro; Richard W Light
Journal:  Respir Med       Date:  2005-04-07       Impact factor: 3.415

7.  The glucose-pH relationship in parapneumonic effusions.

Authors:  D E Potts; D A Taryle; S A Sahn
Journal:  Arch Intern Med       Date:  1978-09

8.  Predictors of outcome and long-term survival in patients with pleural infection.

Authors:  C W Davies; S E Kearney; F V Gleeson; R J Davies
Journal:  Am J Respir Crit Care Med       Date:  1999-11       Impact factor: 21.405

Review 9.  Management of pleural infection in adults: British Thoracic Society Pleural Disease Guideline 2010.

Authors:  Helen E Davies; Robert J O Davies; Christopher W H Davies
Journal:  Thorax       Date:  2010-08       Impact factor: 9.139

Review 10.  Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline.

Authors:  G L Colice; A Curtis; J Deslauriers; J Heffner; R Light; B Littenberg; S Sahn; R A Weinstein; R D Yusen
Journal:  Chest       Date:  2000-10       Impact factor: 9.410

View more
  4 in total

Review 1.  Management of Pleural Infection.

Authors:  Anand Sundaralingam; Radhika Banka; Najib M Rahman
Journal:  Pulm Ther       Date:  2020-12-09

Review 2.  Diagnostics in Pleural Disease.

Authors:  Anand Sundaralingam; Eihab O Bedawi; Najib M Rahman
Journal:  Diagnostics (Basel)       Date:  2020-12-04

Review 3.  From Bedside to the Bench-A Call for Novel Approaches to Prognostic Evaluation and Treatment of Empyema.

Authors:  Sophia Karandashova; Galina Florova; Steven Idell; Andrey A Komissarov
Journal:  Front Pharmacol       Date:  2022-01-20       Impact factor: 5.810

Review 4.  Recent Insights into the Management of Pleural Infection.

Authors:  Maged Hassan; Shefaly Patel; Ahmed S Sadaka; Eihab O Bedawi; John P Corcoran; José M Porcel
Journal:  Int J Gen Med       Date:  2021-07-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.